183 related articles for article (PubMed ID: 31264264)
1. Сlass II histone deacetylases in the post-stroke recovery period-expression, cellular, and subcellular localization-promising targets for neuroprotection.
Demyanenko S; Berezhnaya E; Neginskaya M; Rodkin S; Dzreyan V; Pitinova M
J Cell Biochem; 2019 Dec; 120(12):19590-19609. PubMed ID: 31264264
[TBL] [Abstract][Full Text] [Related]
2. Expression of Class I Histone Deacetylases in Ipsilateral and Contralateral Hemispheres after the Focal Photothrombotic Infarction in the Mouse Brain.
Demyanenko S; Neginskaya M; Berezhnaya E
Transl Stroke Res; 2018 Oct; 9(5):471-483. PubMed ID: 29218547
[TBL] [Abstract][Full Text] [Related]
3. The Neuroprotective Effect of the HDAC2/3 Inhibitor MI192 on the Penumbra After Photothrombotic Stroke in the Mouse Brain.
Demyanenko SV; Nikul VV; Uzdensky AB
Mol Neurobiol; 2020 Jan; 57(1):239-248. PubMed ID: 31512115
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of HDAC6, but not HDAC3 and HDAC4 in the penumbra after photothrombotic stroke in the rat cerebral cortex and the neuroprotective effects of α-phenyl tropolone, HPOB, and sodium valproate.
Demyanenko SV; Dzreyan VA; Uzdensky AB
Brain Res Bull; 2020 Sep; 162():151-165. PubMed ID: 32592806
[TBL] [Abstract][Full Text] [Related]
5. Tubastatin A, an HDAC6 inhibitor, alleviates stroke-induced brain infarction and functional deficits: potential roles of α-tubulin acetylation and FGF-21 up-regulation.
Wang Z; Leng Y; Wang J; Liao HM; Bergman J; Leeds P; Kozikowski A; Chuang DM
Sci Rep; 2016 Jan; 6():19626. PubMed ID: 26790818
[TBL] [Abstract][Full Text] [Related]
6. [Research progress of histone deacetylase 6 inhibitors in the therapy of ischemic stroke].
Zhang CC; Lu F; Liang JQ; Zhou YF
Sheng Li Xue Bao; 2018 Jun; 70(3):301-309. PubMed ID: 29926072
[TBL] [Abstract][Full Text] [Related]
7. Expression patterns of histone deacetylases in experimental stroke and potential targets for neuroprotection.
Chen YT; Zang XF; Pan J; Zhu XL; Chen F; Chen ZB; Xu Y
Clin Exp Pharmacol Physiol; 2012 Sep; 39(9):751-8. PubMed ID: 22651689
[TBL] [Abstract][Full Text] [Related]
8. Selective HDAC6 inhibition prevents TNF-α-induced lung endothelial cell barrier disruption and endotoxin-induced pulmonary edema.
Yu J; Ma Z; Shetty S; Ma M; Fu J
Am J Physiol Lung Cell Mol Physiol; 2016 Jul; 311(1):L39-47. PubMed ID: 27190059
[TBL] [Abstract][Full Text] [Related]
9. HDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytes.
Noack M; Leyk J; Richter-Landsberg C
Glia; 2014 Apr; 62(4):535-47. PubMed ID: 24464872
[TBL] [Abstract][Full Text] [Related]
10. MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors.
Gold WA; Lacina TA; Cantrill LC; Christodoulou J
J Mol Med (Berl); 2015 Jan; 93(1):63-72. PubMed ID: 25209898
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological modulation of HDAC1 and HDAC6 in vivo in a zebrafish model: Therapeutic implications for Parkinson's disease.
Pinho BR; Reis SD; Guedes-Dias P; Leitão-Rocha A; Quintas C; Valentão P; Andrade PB; Santos MM; Oliveira JM
Pharmacol Res; 2016 Jan; 103():328-39. PubMed ID: 26657418
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting histone deacetylase 6 partly protects cultured rat cortical neurons from oxygen‑glucose deprivation‑induced necroptosis.
Yuan L; Wang Z; Liu L; Jian X
Mol Med Rep; 2015 Aug; 12(2):2661-7. PubMed ID: 25976407
[TBL] [Abstract][Full Text] [Related]
13. Deactylase inhibitors disrupt cellular complexes containing protein phosphatases and deacetylases.
Brush MH; Guardiola A; Connor JH; Yao TP; Shenolikar S
J Biol Chem; 2004 Feb; 279(9):7685-91. PubMed ID: 14670976
[TBL] [Abstract][Full Text] [Related]
14. Potential roles of HDAC inhibitors in mitigating ischemia-induced brain damage and facilitating endogenous regeneration and recovery.
Fessler EB; Chibane FL; Wang Z; Chuang DM
Curr Pharm Des; 2013; 19(28):5105-20. PubMed ID: 23448466
[TBL] [Abstract][Full Text] [Related]
15. Modulation of histone deacetylase 6 (HDAC6) nuclear import and tubulin deacetylase activity through acetylation.
Liu Y; Peng L; Seto E; Huang S; Qiu Y
J Biol Chem; 2012 Aug; 287(34):29168-74. PubMed ID: 22778253
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibitor of histone deacetylase 6 (tubastatin A) suppresses proliferation of hepatitis C virus replicon in culture of human hepatocytes.
Kozlov MV; Kleymenova AA; Konduktorov KA; Malikova AZ; Kochetkov SN
Biochemistry (Mosc); 2014 Jul; 79(7):637-42. PubMed ID: 25108326
[TBL] [Abstract][Full Text] [Related]
17. Neuronal complexity is attenuated in preclinical models of migraine and restored by HDAC6 inhibition.
Bertels Z; Singh H; Dripps I; Siegersma K; Tipton AF; Witkowski WD; Sheets Z; Shah P; Conway C; Mangutov E; Ao M; Petukhova V; Karumudi B; Petukhov PA; Baca SM; Rasenick MM; Pradhan AA
Elife; 2021 Apr; 10():. PubMed ID: 33856345
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation.
Dompierre JP; Godin JD; Charrin BC; Cordelières FP; King SJ; Humbert S; Saudou F
J Neurosci; 2007 Mar; 27(13):3571-83. PubMed ID: 17392473
[TBL] [Abstract][Full Text] [Related]
19. Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window.
Lanzillotta A; Pignataro G; Branca C; Cuomo O; Sarnico I; Benarese M; Annunziato L; Spano P; Pizzi M
Neurobiol Dis; 2013 Jan; 49():177-89. PubMed ID: 22971966
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of brain penetrant benzazepine-based histone deacetylase 6 inhibitors for alleviating stroke-induced brain infarction.
Guo Z; Zhang Z; Zhang Y; Wang G; Huang Z; Zhang Q; Li J
Eur J Med Chem; 2021 Jun; 218():113383. PubMed ID: 33799069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
